China Shineway Pharmaceutical Group Limited (FRA:C1S)
Germany flag Germany · Delayed Price · Currency is EUR
0.8800
+0.0050 (0.57%)
Last updated: Sep 29, 2025, 3:29 PM CET

FRA:C1S Statistics

Total Valuation

FRA:C1S has a market cap or net worth of EUR 692.59 million. The enterprise value is -102.01 million.

Market Cap692.59M
Enterprise Value -102.01M

Important Dates

The next estimated earnings date is Thursday, November 27, 2025.

Earnings Date Nov 27, 2025
Ex-Dividend Date Sep 9, 2025

Share Statistics

Current Share Class 755.40M
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 207.04M

Valuation Ratios

The trailing PE ratio is 7.04 and the forward PE ratio is 6.97.

PE Ratio 7.04
Forward PE 6.97
PS Ratio 1.74
PB Ratio 0.75
P/TBV Ratio 0.76
P/FCF Ratio 7.29
P/OCF Ratio 6.04
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.04
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -1.07

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.04.

Current Ratio 3.69
Quick Ratio 3.36
Debt / Equity 0.04
Debt / EBITDA 0.48
Debt / FCF 0.43
Interest Coverage 70.69

Financial Efficiency

Return on equity (ROE) is 10.94% and return on invested capital (ROIC) is 5.10%.

Return on Equity (ROE) 10.94%
Return on Assets (ROA) 3.98%
Return on Invested Capital (ROIC) 5.10%
Return on Capital Employed (ROCE) 8.12%
Revenue Per Employee 138,639
Profits Per Employee 34,337
Employee Count3,220
Asset Turnover 0.33
Inventory Turnover 1.15

Taxes

In the past 12 months, FRA:C1S has paid 27.35 million in taxes.

Income Tax 27.35M
Effective Tax Rate 21.74%

Stock Price Statistics

The stock price has decreased by -11.11% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -11.11%
50-Day Moving Average 0.90
200-Day Moving Average 0.92
Relative Strength Index (RSI) 43.36
Average Volume (20 Days) 1,114

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:C1S had revenue of EUR 397.48 million and earned 98.45 million in profits. Earnings per share was 0.13.

Revenue397.48M
Gross Profit 291.59M
Operating Income 76.81M
Pretax Income 125.79M
Net Income 98.45M
EBITDA 82.60M
EBIT 76.81M
Earnings Per Share (EPS) 0.13
Full Income Statement

Balance Sheet

The company has 827.42 million in cash and 40.57 million in debt, giving a net cash position of 786.85 million.

Cash & Cash Equivalents 827.42M
Total Debt 40.57M
Net Cash 786.85M
Net Cash Per Share n/a
Equity (Book Value) 928.26M
Book Value Per Share 1.23
Working Capital 775.55M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 114.74 million and capital expenditures -19.76 million, giving a free cash flow of 94.98 million.

Operating Cash Flow 114.74M
Capital Expenditures -19.76M
Free Cash Flow 94.98M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 73.36%, with operating and profit margins of 19.32% and 24.77%.

Gross Margin 73.36%
Operating Margin 19.32%
Pretax Margin 31.65%
Profit Margin 24.77%
EBITDA Margin 20.78%
EBIT Margin 19.32%
FCF Margin 23.90%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 6.47%.

Dividend Per Share 0.06
Dividend Yield 6.47%
Dividend Growth (YoY) -18.05%
Years of Dividend Growth 2
Payout Ratio 42.87%
Buyback Yield n/a
Shareholder Yield 6.47%
Earnings Yield 14.21%
FCF Yield 13.71%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:C1S has an Altman Z-Score of 3.7 and a Piotroski F-Score of 5.

Altman Z-Score 3.7
Piotroski F-Score 5